![FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News](https://www.notebookcheck.net/fileadmin/Notebooks/News/_nc3/Eversense_CGM_system_90_day_now_180_days_blood_glucose_drdNBC.jpg)
FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News
![Germantown's Senseonics Announces FDA Approval of the World's First and Only Long-Term Implantable Glucose Monitoring System - The MoCo Show Germantown's Senseonics Announces FDA Approval of the World's First and Only Long-Term Implantable Glucose Monitoring System - The MoCo Show](https://mocoshow.com/wp-content/uploads/2022/02/Senseonics.jpg)
Germantown's Senseonics Announces FDA Approval of the World's First and Only Long-Term Implantable Glucose Monitoring System - The MoCo Show
![Eversense E3 CGM: An Innovative Leap in Diabetes Management | Endocrinology & Psychiatry located in Houston and Katy, TX | Endocrine and Psychiatry Center Eversense E3 CGM: An Innovative Leap in Diabetes Management | Endocrinology & Psychiatry located in Houston and Katy, TX | Endocrine and Psychiatry Center](https://sa1s3optim.patientpop.com/filters:format(webp)/assets/images/provider/photos/2654529.jpg)